10.8. The following budget has been set for 2026-27:
Research Funding by area 2026-27
NIHR Oxford Biomedical Research Centre (BRC) 18
NIHR Regional Research Delivery Network (RRDN) 9
NIHR Research Capability Funding (RCF) 1
Other income (commercial & non-commercial, incl. NIHR grants) 24
Expenditure budget (£m)
Total 52
10.9. As in previous years the BRC and RRDN budgets forecast a break-even position for 2026-27.
10.10. For budget setting purposes it had been assumed that OUH will receive a similar level of RCF funding to last year (£580k). An award of £1.123m was confirmed in June 2026.
10.11. The budget for income (and expenditure) from commercial and other non-commercial studies, including other NIHR grants, has been set at £24 million which is based on income trends in recent years.
11.1. During 2025-26, 1,445 research and IP related cases were finalised. Further details are provided in the Appendix.
12.1. The lead authors would like to thank the following colleagues for drafting relevant sections of this report and all the members of the teams they lead, whose work it describes:
Jennifer Anderson (Head of BRC Operations)
Kirsten Bailey (Head of R&D Finance)
Tim Bradford (Head of R&D Information Systems)
Cushla Cooper (Clinical Operational Lead, Oxford CRF)
Shahista Hussain (Head of R&D Governance; Deputy Head of R&D Operations)
Charles Lescott (Head of IP and Research Contracts)
Sandie Wellman (Head of NMAHP Clinical Research Delivery)